Fact CheckerSign in

NCT06361407Recruiting

Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

Disturbances in the sense of self and time could play an important role in the development of psychotic symptoms. Previous work has shown that patients have difficulty preparing to process information on the scale of a second, but are abnormally disturbed by slightly asynchronous information on the millisecond scale. In both cases, the anomalies could explain the patients' unusual experience of time. The hypothesis in neurotypical patients is that small delays or asynchronies asynchronies are treated as irrelevant information and ignored and ignored, whereas in patients suffering from schizophrenia they would disrupt the flow of time. This hypothesis is tested with a new visual illusion.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
68 (estimated)
First submitted
3 Apr 2024
Start date
28 Jun 2024
Primary completion date
28 Oct 2027
Lead sponsor
Centre Psychothérapique de Nancy
NCT number
NCT06361407

What you commit to

  • Study type: Interventional
  • Planned participants: 68
  • From 28 Jun 2024 to the primary completion date, 28 Oct 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Psychoactive substance use disorders (as defined by the DSM-V) (Diagnostic and Statistical Manual-V);
  • Attention deficit hyperactivity disorder (ADHD);
  • Borderline personality disorder;
  • Disabling sensory disorders (visual acuity \<0.8);

Other

  • Use of benzodiazepines, hallucinogens (in the period preceding before inclusion, for a duration equivalent to 5 half-lives of the product) or cannabis (in the 2 months preceding inclusion);
  • Neurological pathology or sequelae;
  • Person deprived of liberty or under court protection;
  • Pregnant, parturient or breast-feeding women;
  • Subjects in a period of exclusion defined by another clinical study.

Who the study is looking for

  • Male or female;
  • Age between 18 and 60 inclusive;
  • Subject having dated and signed the consent form prior to the start of any trial-related procedure (guardian or curator where applicable);
  • Member of a social security scheme or beneficiary of such a scheme.

Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Sainte Marguerite, APHM
Coordinator of this site? Confirm its status
MarseilleFranceRecruiting
Centre Hospitalier Drôme Vivarais
Coordinator of this site? Confirm its status
MontélégerFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.